2 hrs ago | Medical News
Ensemble, Genentech enter macrocyclic drug discovery collaboration
Ensemble Therapeutics, a biotechnology company developing EnsemblinsTM, a novel class of small molecule therapeutics with the power of biologics, today announced the initiation of a drug discovery collaboration with Genentech, a member of the Roche Group , to discover macrocyclic drug candidates against targets specified by Genentech.
Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
TUCSON, Ariz., May 21, 2012 /PRNewswire/ -- Ventana Medical Systems, Inc. , a member of the Roche Group, announced today that it has co-exclusively sub-licensed certain patents and patent applications from Gen-Probe Incorporated for the worldwide in vitro diagnostic rights for measuring ERG protein expression through immunohistochemistry in ... (more)
Curis, Inc. Announces Collaborator Roche's Submission of Erivedge(TM) ...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Curis, Inc.
Swiss drug maker Roche sees Q1 sales stutter
Swiss drug maker Roche Holding AG reported Thursday that group sales dipped one percent to 11.03 billion Swiss francs in the first quarter, while hinting that it might be prepared to raise its offer for U.S. diagnostics firm Illumina Inc.